Oral Delivery Systems for Gasotransmitters in Therapeutic Applications
Polymer Science & Technology · 24.03.2026 · 2 (3) · 114-135
DOI: 10.1021/polymscitech.5c00068 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Polymer Science & Technology, online erschienen am 07.07.2025. Verfasst von Yongwu Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The First Affiliated Hospital of the University of Science and Technology of China and Hefei National Research Center for Phy…. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: University of Science and Technology of China, National Natural Science Foundation of China, Chinese Academy of Sciences.
Abstract (Originalsprache)
Gasotransmitters, including nitric oxide (NO), carbon monoxide (CO), and hydrogen sulfide (H2S), are critically involved in a broad spectrum of physiological and pathological processes, such as vasodilation, neurotransmission, immune modulation, and antioxidant defense. Due to their diverse biological activities, these gasotransmitters have attracted increasing interest as potential therapeutic agents. However, their clinical application remains limited by intrinsic physicochemical challenges, including short half-lives and low targeting specificity, which complicate efficient delivery. In recent years, oral delivery approaches have received growing attention in gasotransmitter-based therapy owing to their noninvasive administration, high patient compliance, and potential for both systemic and localized effects. Polymer-based delivery systems play a pivotal role in the oral administration of gasotransmitters by enabling controlled release, protecting labile molecules from degradation, and enhancing their bioavailability. This Review systematically summarizes recent advances in the oral delivery of NO, CO, and H2S, with particular emphasis on prodrug design, controlled release systems, carrier engineering, and in vivo release mechanisms. Furthermore, the major technological barriers to clinical translation are critically discussed. Finally, future perspectives are outlined to inform the rational design of optimized oral delivery platforms for therapeutic gases.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy, The First Affiliated Hospital of the University of Science and Technology of China and Hefei National Research Center for Physical Sciences at the Microscale, Department of Polymer Science and En…
ORCID-Profile: Jinming Hu
Förderung
- University of Science and Technology of China
- National Natural Science Foundation of China
- Chinese Academy of Sciences
Zitieren
APA
Chen, Y., Sheng, J., Cheng, J., Tang, L., & Hu, J. (2026). Oral Delivery Systems for Gasotransmitters in Therapeutic Applications. Polymer Science & Technology, 2(3), 114-135. https://doi.org/10.1021/polymscitech.5c00068
Vancouver
Chen Y, Sheng J, Cheng J, Tang L, Hu J. Oral Delivery Systems for Gasotransmitters in Therapeutic Applications. Polymer Science & Technology. 2026;2(3):114-135. doi:10.1021/polymscitech.5c00068
BibTeX
@article{Chen2026,
author = {Chen, Yongwu and Sheng, Jiahui and Cheng, Jian and Tang, Liqin and Hu, Jinming},
title = {Oral Delivery Systems for Gasotransmitters in Therapeutic Applications},
journal = {Polymer Science & Technology},
year = {2026},
volume = {2},
number = {3},
pages = {114--135},
doi = {10.1021/polymscitech.5c00068}
}
EUVIMED